Juliette Gafni, Ph.D.
Affiliations: | University of California, Davis, Davis, CA |
Google:
"Juliette Gafni"Mean distance: 15.62 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentorKaren A. Sigvardt | grad student | 2000 | UC Davis | |
(Novel modulators of microsomal calcium release.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Miller JP, Yates BE, Al-Ramahi I, et al. (2012) A genome-scale RNA-interference screen identifies RRAS signaling as a pathologic feature of Huntington's disease. Plos Genetics. 8: e1003042 |
Gafni J, Papanikolaou T, Degiacomo F, et al. (2012) Caspase-6 activity in a BACHD mouse modulates steady-state levels of mutant huntingtin protein but is not necessary for production of a 586 amino acid proteolytic fragment. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 7454-65 |
Leyva MJ, Degiacomo F, Kaltenbach LS, et al. (2010) Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease models. Chemistry & Biology. 17: 1189-200 |
Miller JP, Holcomb J, Al-Ramahi I, et al. (2010) Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease. Neuron. 67: 199-212 |
Landles C, Sathasivam K, Weiss A, et al. (2010) Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. The Journal of Biological Chemistry. 285: 8808-23 |
Gafni J, Cong X, Chen SF, et al. (2009) Calpain-1 cleaves and activates caspase-7. The Journal of Biological Chemistry. 284: 25441-9 |
Schilling B, Gafni J, Torcassi C, et al. (2006) Huntingtin phosphorylation sites mapped by mass spectrometry. Modulation of cleavage and toxicity. The Journal of Biological Chemistry. 281: 23686-97 |
Tanaka Y, Igarashi S, Nakamura M, et al. (2006) Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin. Neurobiology of Disease. 21: 381-91 |
Jin K, LaFevre-Bernt M, Sun Y, et al. (2005) FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America. 102: 18189-94 |
Gafni J, Hermel E, Young JE, et al. (2004) Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus. The Journal of Biological Chemistry. 279: 20211-20 |